← All diseases Autoimmune diseases

Autoimmune hepatitis, advanced

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (41)Meta-analysis (14)Treatment guideline (6)Systematic review (12)Randomized trial (5)Phase 3 study (4)Clinical trial (162)Review Article (288)Early study (phase 1 or 2) (7)Case descriptions (320)Laboratory or animal study (27)Commentary or editorial (69) Only studies currently seeking participants (26)

Filter

Publications and studies (1593)

• Commentary or editorialiAn expert's opinion or commentary, not new research. Alopecia in Patients with Autoimmune Hepatitis Treated by Tacrolimus Therapy. (2024/05/28) ♡
• Good long-term outcomes of primary sclerosing cholangitis in childhood. (2024/05/25) ♡
• YTHDF1 shapes immune-mediated hepatitis via regulating inflammatory cell recruitment and response. (2024/05/16) ♡
• Leptin gene Polymorphism and Leptin protein levels in Pediatric Autoimmune Hepatitis. (2024/05/03) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Reply: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis. (2024/05/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe Acute Liver Injury: First Manifestation of Systemic Lupus Erythematosus. (2024/05/01) ♡
• Efficacy of Yttrium-90 Transarterial Radioembolisation in Advanced Hepatocellular Carcinoma: An Experience With Hybrid Angio-Computed Tomography and Glass Microspheres. (2024/05/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Striking Cholestatic Giant Cell Hepatitis Resulting in Fulminant Liver Failure After Garcinia Cambogia Use. (2024/05/01) ♡
• Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United States. (2024/05/01) ♡
• Granulomas in Pediatric Liver Biopsies: Single Center Experience. (2024/05/01) ♡
• Impact of ursodeoxycholic acid therapy in autoimmune liver disease patients with COVID-19 and its clinical prognosis. (2024/04/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Autoimmune hepatitis presenting as severe anemia. (2024/04/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Novel Subtype of Acquired Generalized Lipodystrophy Associated With Subcutaneous Panniculitis-Like T-cell Lymphoma. (2024/04/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case study: autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks' gestation. (2024/04/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple autoimmune disorders refractory to glucocorticoids after allogeneic hematopoietic stem cell transplantation: a case report and review of the literature. (2024/04/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ocular manifestations of liver disease: an important diagnostic aid. (2024/04/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Complementary and alternative medicines and liver disease. (2024/04/03) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Reply: Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome-First report of the IAIHG retrospective registry. (2024/04/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Letter to the Editor: Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome-First report of the IAIHG retrospective registry. (2024/04/01) ♡
• Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort. (2024/04/01) ♡
• FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis. (2024/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Autoimmune hepatitis recurrence after liver transplantation: "Les jeux sont faits". (2024/04/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis. (2024/04/01) ♡
• Quantitative digital pathology enables automated and quantitative assessment of inflammatory activity in patients with autoimmune hepatitis. (2024/03/12) ♡
• Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. (2024/03/07) ♡
• MiR-326 sponges TET2 triggering imbalance of Th17/Treg differentiation to exacerbate pyroptosis of hepatocytes in concanavalin A-induced autoimmune hepatitis. (2024/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical Management of Gastrointestinal and Liver Toxicities of Immune Checkpoint Inhibitors. (2024/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease. (2024/03/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry. (2024/03/01) ♡
• Phenome-wide Mendelian randomization analysis reveals multiple health comorbidities of coeliac disease. (2024/03/01) ♡
• Have serum vitamin D and ferritin a role in predicting the prognosis of autoimmune hepatitis treatment in children? (2024/03/01) ♡
• Glucocorticoid receptors: The key of the response to steroid therapy in autoimmune hepatitis. (2024/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progress in the Correlation Between Inflammasome NLRP3 and Liver Fibrosis. (2024/02/28) ♡
• Safety and Immunogenicity After Primary and Booster Inactivated SARS-Cov-2 Vaccination in Patients with Autoimmune Liver Diseases. (2024/02/28) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Interleukins in liver disease treatment. (2024/02/27) ♡
• Alanine Aminotransferase (ALT) Test. (2024/02/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Celiac crisis, transient hypertransaminasemia and positive smooth muscle antibodies (SMA): A celiac disease case report. (2024/02/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Protective effects of hepatic diseases by bioactive phytochemicals in Fusarium oxysporum - A review. (2024/02/20) ♡
• Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies. (2024/02/19) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. L-lysine supplementation attenuates experimental autoimmune hepatitis in a chronic murine model. (2024/02/14) ♡
• Reply to letter to the editor in response to: Distinguishing autoimmune hepatitis from steatohepatitis in adolescents with obesity and positive screening alanine aminotransferase. (2024/02/12) ♡
• Tregs protect against invariant NKT cell-mediated autoimmune colitis and hepatitis. (2024/02/01) ♡
• Drug repurposing screen identifies vidofludimus calcium and pyrazofurin as novel chemical entities for the development of hepatitis E interventions. (2024/02/01) ♡
• Defining characteristics and long-term prognosis of drug-induced autoimmune-like hepatitis: A retrospective cohort study. (2024/02/01) ♡
• Presence of ectopic germinal center structures in autoimmune hepatitis. (2024/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Elevated liver enzymes: unusual presentation of anti-MDA5 antibody-associated juvenile dermatomyositis. (2024/02/01) ♡
• Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis. (2024/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. IPEX Syndrome. (2024/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Pediatric Autoimmune Hepatitis. (2024/02/01) ♡
• Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease. (2024/01/24) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.